JPS5718615A - Anticataract agent - Google Patents
Anticataract agentInfo
- Publication number
- JPS5718615A JPS5718615A JP9287680A JP9287680A JPS5718615A JP S5718615 A JPS5718615 A JP S5718615A JP 9287680 A JP9287680 A JP 9287680A JP 9287680 A JP9287680 A JP 9287680A JP S5718615 A JPS5718615 A JP S5718615A
- Authority
- JP
- Japan
- Prior art keywords
- cystein
- anticataract
- salt
- coom
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
PURPOSE: An anticataract that contains a cystein-glucuronate salt as an active principle, thus showing low toxicity.
CONSTITUTION: The objective anticataract contains a cystein-glucuronate salt of the formula (COOM1 is carboxylate salt; COOM2 are free carboxyl or carboxylate salt) and is made into a preparation such as tablets, pills for oral administration or injection solution or eye drop. The preparation is used to prevent the development of cataract or sotp the progress and the oral dose for adult is 1W5,000mg, preferably 10W2,000mg a day. The compound of the formula is obtained by reaction between cystein and gulcuronic acid in an aqueous medium in the presence of sodium hydroxide.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9287680A JPS5718615A (en) | 1980-07-07 | 1980-07-07 | Anticataract agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9287680A JPS5718615A (en) | 1980-07-07 | 1980-07-07 | Anticataract agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5718615A true JPS5718615A (en) | 1982-01-30 |
JPH0157092B2 JPH0157092B2 (en) | 1989-12-04 |
Family
ID=14066641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9287680A Granted JPS5718615A (en) | 1980-07-07 | 1980-07-07 | Anticataract agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5718615A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3714322A1 (en) * | 1986-05-01 | 1987-11-05 | Senju Pharma Co | PROPHYLACTIC AND THERAPEUTIC AGENT FOR HEPATITIC DISEASES |
JPH02202818A (en) * | 1988-12-09 | 1990-08-10 | Allergan Inc | Use of 2-substitution-thiazolizine -4-carboxylic acid or the like for cataract therapy |
-
1980
- 1980-07-07 JP JP9287680A patent/JPS5718615A/en active Granted
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3714322A1 (en) * | 1986-05-01 | 1987-11-05 | Senju Pharma Co | PROPHYLACTIC AND THERAPEUTIC AGENT FOR HEPATITIC DISEASES |
FR2598082A1 (en) * | 1986-05-01 | 1987-11-06 | Senju Pharma Co | PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE TREATMENT OF HEPATIC DISORDERS |
GB2189996A (en) * | 1986-05-01 | 1987-11-11 | Senju Pharma Co | Cysteineglucuronic acid as a prophylactic and therapeutic agent |
GB2189996B (en) * | 1986-05-01 | 1990-05-02 | Senju Pharma Co | Prophylactic and therapeutic agent for hepatic disorder |
JPH02202818A (en) * | 1988-12-09 | 1990-08-10 | Allergan Inc | Use of 2-substitution-thiazolizine -4-carboxylic acid or the like for cataract therapy |
Also Published As
Publication number | Publication date |
---|---|
JPH0157092B2 (en) | 1989-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5671073A (en) | Imidazole derivative | |
FI945452A0 (en) | An ibuprofen containing borne pharmaceutical composition and a process for its manufacture | |
US4455305A (en) | Composition for the treatment of colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronic nonspecific colitis and diverticulitis and the use of salicylazobenzoic acid for the preparation of such compositions | |
IE43653L (en) | Sequestration of oxygen dissolved in water | |
JPS5551020A (en) | Remedy for rheumatism | |
JPS52128210A (en) | Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives | |
JPS5718615A (en) | Anticataract agent | |
IT1229502B (en) | COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE. | |
CA2038025A1 (en) | Optically active alkylenedioxybenzene derivatives and their use in therapy | |
JPS57158719A (en) | Rectal administration pharmaceutical | |
ES8501760A1 (en) | Pyrrolidinone derivatives, their preparation and pharmaceutical compositions containing them. | |
JPS56152418A (en) | Hypoglycemic agent | |
JPS57106644A (en) | Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation | |
JPS5731688A (en) | Protoporphyrin germanium complex and its preparation | |
JPS5566509A (en) | Carcinostatic | |
JPS5527133A (en) | Drug comprising organosilicon compound as main constituent | |
JPS57108016A (en) | Antithrombotic agent | |
JPS5569510A (en) | Carcinostatic agent | |
GB1199758A (en) | Arylsulphonyl-Semicarbazides and their production | |
JPS5489037A (en) | Anti-ulcer agent | |
AU7971182A (en) | Anthranilic acid derivatives | |
JPS5780315A (en) | Absorption promotor for accelerating rectum absorption, base comprising it, and pharmaceutical preparation to be medicated to rectum | |
JPS57181012A (en) | Drug composed of polyprenyl compound | |
JPS57108017A (en) | Antithrombotic agent | |
JPS5634625A (en) | Antitumorigenic agent |